Latest News and Press Releases

EpiCept Corporation and FDA Agree on Development Plan for Ceplene® Phase III Trial to be Conducted under a Special Protocol Assessment TARRYTOWN, N.Y.--(BUSINESS...

EpiCept Receives Nasdaq Listing Notices Company Has until April 2011 to Regain Compliance TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...

EpiCept Corporation to Present at the 9th Annual BIO Investor Forum NP-1 Interim Data from NCI-Sponsored Clinical Trial to Be Discussed Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX...

EpiCept Corporation to Present at the Rodman & Renshaw 12th Annual Global Investment Conference TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...

EpiCept Corporation Receives Refusal to File Letter from US FDA on Ceplene New Drug Application COMPANY TO REQUEST MEETING WITH FDA TO DISCUSS RESPONSE TARRYTOWN, N.Y.--(BUSINESS...

EpiCept Corporation Reports Second Quarter 2010 Operating and Financial Results Conference Call Begins at 9:00 A.M. Eastern Time TARRYTOWN, N.Y.--(BUSINESS...

EpiCept to Report Second Quarter 2010 Operating and Financial Results on August 6, 2010 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq...

EpiCept Amends Employment Agreement and Completes Severance Agreements with Executive Officers TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...

EpiCept Increases Exercise Price of Warrants in June 2010 Offering TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic...

EpiCept Corporation Names Rita Kelley Senior Director of Marketing TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic...